Antiretroviral tolerability and efficacy after switch to saquinavir in PI-experienced patients : 48-week analysis of the German Rainbow Cohort

Poster presentation: Purpose of the study The aim of the Rainbow Cohort is to assess the tolerability and efficacy of initiating treatment with, or switching treatment to the saquinavir (SQV) 500 mg film-coated tablet fo
Poster presentation: Purpose of the study The aim of the Rainbow Cohort is to assess the tolerability and efficacy of initiating treatment with, or switching treatment to the saquinavir (SQV) 500 mg film-coated tablet formulation. We present the final 48-week subgroup analysis of PI-experienced, but SQV-naïve patients. ...
show moreshow less

Download full text files

Export metadata

  • Export Bibtex
  • Export RIS

Additional Services

    Share in Twitter Search Google Scholar
Metadaten
Author:Christoph Stephan, Hans Jäger, Andreas Carganico, Gaby Knecht, Thomas Lutz, Christoph Mayr, Franz Mosthaf, Siegfried Koeppe, Markus Mueller, Eva Wolf, Andre Tappe, Egbert Wellmann, Heribert Knechten
URN:urn:nbn:de:hebis:30-70723
Document Type:Article
Language:English
Date of Publication (online):2008/11/10
Year of first Publication:2008
Publishing Institution:Univ.-Bibliothek Frankfurt am Main
Release Date:2009/09/20
Note:
© 2008 Stephan et al; licensee BioMed Central Ltd.
Source:Journal of the International AIDS Society 2008, 11(Suppl 1):P25 ; doi:10.1186/1758-2652-11-S1-P25 ; from Ninth International Congress on Drug Therapy in HIV Infection Glasgow, UK. 9–13 November 2008
HeBIS PPN:21888463X
Institutes:Medizin
Dewey Decimal Classification:610 Medizin und Gesundheit
Sammlungen:Universitätspublikationen
Licence (German):License Logo Veröffentlichungsvertrag für Publikationen

$Rev: 11761 $